NCT06366633

Brief Summary

The investigator aims to conduct an open pilot study (N=6; 5 completers) to test the feasibility, acceptability, and credibility of an asynchronous web-based mind-body intervention (Toolkit for Resilient Life beyond Pain and Substance Use; Web-TIRELESS) for adult patients with a comorbidity of non-traumatic painful upper-extremity condition(s) (NPUC) and risky substance use. Deliverables: 1) Adapt and refine open pilot protocol, patient recruitment, and other study materials. 2) Assess the feasibility, acceptability, and credibility of Web- TIRELESS in preparation for a future feasibility RCT. Participants will complete 4 on-demand video sessions at their own pace (approximate pace of 1 session per week) and complete baseline and post-test assessments. participants may also partake in an exit interview to provide feedback on Web-TIRELESS to further refine the program and study protocol for future iterations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

April 16, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

October 29, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

7 months

First QC Date

March 28, 2024

Last Update Submit

February 13, 2026

Conditions

Keywords

Upper Extremity ConditionRisky substance UseMindfulnessNontraumatic conditionsChronic pain

Outcome Measures

Primary Outcomes (8)

  • Credibility and Expectancy Questionnaire (CEQ)

    Assesses the degree to which one believes the intervention will effectively manage their condition, substance use, and related worry. Possible scores range from 3 to 27 for both the credibility and the expectancy subscales. Higher scores represent higher credibility and expectancy.

    Baseline (0 Weeks)

  • Client Satisfaction Questionnaire to assess satisfaction with/acceptability of treatment

    Participant's satisfaction with treatment received after completion . The score range is 0-12. Higher scores indicate greater satisfaction.

    Post-Test (4 Weeks)

  • The User Experience Scale to assess participants' satisfaction with (acceptability of) web-based delivery

    This measure will assess how well patients like the Wed-based program content and delivery. Total raw scores range from 22 to 110 with higher scores indicating greater satisfaction with the platform.

    Post-Test (4 Weeks)

  • The percent of patients that agree to participate to assess feasibility of recruitment

    The percent of eligible patients approached that agree to participate.

    Baseline (0 Weeks)

  • Rate at which program was accepted, measured by attendance to assess acceptability of treatment

    The proportion of participants who complete \> or = 3 of 4 sessions.

    Post-Test (4 Weeks)

  • Adherence to homework

    Rate of participant's completion of homework assigned throughout the study.

    Through intervention completion, an average of 1 month

  • Rate of participant's completion of self-report measures to assess feasibility of assessments

    Investigators will report number of patients who complete assessments at each time-point.

    Baseline (0 Weeks), Post-Test (4 Weeks)

  • Adverse Events

    Any self-reported or observed negative events related to participation

    Through study completion, an average of 1 month

Secondary Outcomes (11)

  • Graded Chronic Pain Scale (GCPS)

    Baseline (0 Weeks), Post-Test (4 Weeks)

  • Disabilities of the Arm, Shoulder and Hand (DASH)

    Baseline (0 Weeks), Post-Test (4 Weeks)

  • Patient Reported Outcomes Measurement Information System (PROMIS) Emotional Distress - Depression-Short Form 8b v1.0

    Baseline (0 Weeks), Post-Test (4 Weeks)

  • PROMIS Emotional Distress - Anxiety-Short Form 8b v1.0

    Baseline (0 Weeks), Post-Test (4 Weeks)

  • Pain Catastrophizing Scale (PCS)

    Baseline (0 Weeks), Post-Test (4 Weeks)

  • +6 more secondary outcomes

Study Arms (1)

Web-TIRELESS

EXPERIMENTAL

An asynchronous web-based mind-body intervention focused on decreasing disability, pain, risky substance use, and related distress in patients with nontraumatic upper-extremity conditions and comorbid risky substance use.

Behavioral: Web-TIRELESS

Interventions

Web-TIRELESSBEHAVIORAL

This is a self-administered web-based intervention that consists of 4 30-45-minute video sessions that teach mind-body skills, cognitive-behavioral strategies (e.g., reframing, pain and substance use urge surfing), activity pacing, acceptance and commitment skills, and psychoeducation on the association between substance use and pain. The program aims to increase patients' physical and emotional functioning and decrease pain intensity and maladaptive substance use behaviors.

Web-TIRELESS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Outpatient adults seeking care in the Hand and Arm Center
  • Diagnosed with a non-traumatic painful upper-extremity condition (NPUC)
  • Pain score \> 4 on the Numerical Rating Scale (NRS)
  • Risky substance use (scores \>10 and \<27 for alcohol, and \>3 and \<27 for cannabis, cocaine, amphetamine-type stimulants, inhalants, sedatives, hallucinogens, opioids, tobacco products, and e-cigarette on The World Health Organization's - Alcohol, Smoking and Substance Involvement Screening Test \[WHO-ASSIST\])
  • Owns a smartphone, laptop, or computer with internet access
  • Age ≥18yr
  • English fluency
  • Ability and willingness to participate in a live video focus group and the following asynchronous Web-based intervention

You may not qualify if:

  • Participation in mind-body or specialized substance abuse treatment in the past 3 months
  • Practice of mindfulness \>45 minutes/week in the past 3 months
  • Psychotropic medications (e.g. antidepressants) changed in the past 3 months
  • Serious untreated mental illness (e.g., Schizophrenia)
  • Suicidal ideation with intent or plan
  • Pregnancy
  • Secondary gains that may bias motivation (e.g., pending disability claim),
  • Moderate to severe cognitive impairment (score ≥4 on the Short Portable Mental Status Questionnaire (SPMSQ))
  • History of surgery for the presented NPUC within the past 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital (MGH)

Boston, Massachusetts, 02129, United States

Location

Related Publications (1)

  • Levey N, Chen N, Ditre J, Sylvia L, Mudgal C, Bhashyam A, Garg R, Ring D, Vranceanu AM, Bakhshaie J. A Web-Based Mind-Body Intervention to Improve Resilience Among Patients With Nontraumatic Painful Upper-Extremity Conditions and Comorbid Risky Substance Use: Protocol for a Mixed Methods Study. JMIR Res Protoc. 2024 Dec 9;13:e64547. doi: 10.2196/64547.

MeSH Terms

Conditions

Musculoskeletal DiseasesSubstance-Related DisordersChronic Pain

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental DisordersPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jafar Bakhshaie, MD, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 28, 2024

First Posted

April 16, 2024

Study Start

October 29, 2024

Primary Completion

May 31, 2025

Study Completion

July 31, 2025

Last Updated

February 18, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations